130 related articles for article (PubMed ID: 35750276)
21. Essential role of CK2α for the interaction and stability of replication fork factors during DNA synthesis and activation of the S-phase checkpoint.
Guerra B; Doktor TK; Frederiksen SB; Somyajit K; Andresen BS
Cell Mol Life Sci; 2022 Jun; 79(6):339. PubMed ID: 35661926
[TBL] [Abstract][Full Text] [Related]
22. Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress.
Liu S; Opiyo SO; Manthey K; Glanzer JG; Ashley AK; Amerin C; Troksa K; Shrivastav M; Nickoloff JA; Oakley GG
Nucleic Acids Res; 2012 Nov; 40(21):10780-94. PubMed ID: 22977173
[TBL] [Abstract][Full Text] [Related]
23. An extending ATR-CHK1 circuitry: the replication stress response and beyond.
Simoneau A; Zou L
Curr Opin Genet Dev; 2021 Dec; 71():92-98. PubMed ID: 34329853
[TBL] [Abstract][Full Text] [Related]
24. Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer.
Meyer F; Becker S; Classen S; Parplys AC; Mansour WY; Riepen B; Timm S; Ruebe C; Jasin M; Wikman H; Petersen C; Rothkamm K; Borgmann K
Cells; 2020 Jan; 9(1):. PubMed ID: 31963582
[TBL] [Abstract][Full Text] [Related]
25. Restored replication fork stabilization, a mechanism of PARP inhibitor resistance, can be overcome by cell cycle checkpoint inhibition.
Haynes B; Murai J; Lee JM
Cancer Treat Rev; 2018 Dec; 71():1-7. PubMed ID: 30269007
[TBL] [Abstract][Full Text] [Related]
26. SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.
Jo U; Murai Y; Chakka S; Chen L; Cheng K; Murai J; Saha LK; Miller Jenkins LM; Pommier Y
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33536335
[TBL] [Abstract][Full Text] [Related]
27. DNA-PK phosphorylation of RPA32 Ser4/Ser8 regulates replication stress checkpoint activation, fork restart, homologous recombination and mitotic catastrophe.
Ashley AK; Shrivastav M; Nie J; Amerin C; Troksa K; Glanzer JG; Liu S; Opiyo SO; Dimitrova DD; Le P; Sishc B; Bailey SM; Oakley GG; Nickoloff JA
DNA Repair (Amst); 2014 Sep; 21():131-9. PubMed ID: 24819595
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy.
Massey AJ
Cancer Lett; 2016 Dec; 383(1):41-52. PubMed ID: 27693461
[TBL] [Abstract][Full Text] [Related]
29. ATR checkpoint kinase and CRL1βTRCP collaborate to degrade ASF1a and thus repress genes overlapping with clusters of stalled replication forks.
Im JS; Keaton M; Lee KY; Kumar P; Park J; Dutta A
Genes Dev; 2014 Apr; 28(8):875-87. PubMed ID: 24700029
[TBL] [Abstract][Full Text] [Related]
30. Chk1 dynamics in G2 phase upon replication stress predict daughter cell outcome.
Lebrec V; Poteau M; Morretton JP; Gavet O
Dev Cell; 2022 Mar; 57(5):638-653.e5. PubMed ID: 35245445
[TBL] [Abstract][Full Text] [Related]
31. STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation.
Koganti S; Hui-Yuen J; McAllister S; Gardner B; Grasser F; Palendira U; Tangye SG; Freeman AF; Bhaduri-McIntosh S
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4946-51. PubMed ID: 24639502
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of Minichromosome Maintenance 3 (MCM3) by Checkpoint Kinase 1 (Chk1) Negatively Regulates DNA Replication and Checkpoint Activation.
Han X; Mayca Pozo F; Wisotsky JN; Wang B; Jacobberger JW; Zhang Y
J Biol Chem; 2015 May; 290(19):12370-8. PubMed ID: 25809478
[TBL] [Abstract][Full Text] [Related]
33. On the Interplay of the DNA Replication Program and the Intra-S Phase Checkpoint Pathway.
Ciardo D; Goldar A; Marheineke K
Genes (Basel); 2019 Jan; 10(2):. PubMed ID: 30700024
[TBL] [Abstract][Full Text] [Related]
34. The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress.
Zhang YW; Brognard J; Coughlin C; You Z; Dolled-Filhart M; Aslanian A; Manning G; Abraham RT; Hunter T
Mol Cell; 2009 Aug; 35(4):442-53. PubMed ID: 19716789
[TBL] [Abstract][Full Text] [Related]
35. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.
Demidova AR; Aau MY; Zhuang L; Yu Q
J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337
[TBL] [Abstract][Full Text] [Related]
36. ATR mediates cisplatin resistance in 3D-cultured breast cancer cells via translesion DNA synthesis modulation.
Gomes LR; Rocha CRR; Martins DJ; Fiore APZP; Kinker GS; Bruni-Cardoso A; Menck CFM
Cell Death Dis; 2019 Jun; 10(6):459. PubMed ID: 31189884
[TBL] [Abstract][Full Text] [Related]
37. A clinically relevant heterozygous ATR mutation sensitizes colorectal cancer cells to replication stress.
Egger T; Bordignon B; Coquelle A
Sci Rep; 2022 Mar; 12(1):5422. PubMed ID: 35361811
[TBL] [Abstract][Full Text] [Related]
38. Targeting ATR and Chk1 kinases for cancer treatment: a new model for new (and old) drugs.
Toledo LI; Murga M; Fernandez-Capetillo O
Mol Oncol; 2011 Aug; 5(4):368-73. PubMed ID: 21820372
[TBL] [Abstract][Full Text] [Related]
39. Chk1 inhibits E2F6 repressor function in response to replication stress to maintain cell-cycle transcription.
Bertoli C; Klier S; McGowan C; Wittenberg C; de Bruin RA
Curr Biol; 2013 Sep; 23(17):1629-37. PubMed ID: 23954429
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of TopBP1, a canonical ATR/Chk1 activator, paradoxically hinders ATR/Chk1 activation in cancer.
Liu K; Graves JD; Lin FT; Lin WC
J Biol Chem; 2021; 296():100382. PubMed ID: 33556369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
